Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast...

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Increasing demand for nanoparticle drug efficacy to improve tumor targeting and reduce systemic toxicity.
• Current nanomedicine targeting often involves complex synthesis and preparation methods.
• Need for simpler, effective strategies for targeted drug delivery.

Purpose of the Study:

• To develop a simple and effective pH-sensitive nanoparticle system for targeted drug delivery.
• To utilize polydopamine (PDA) as a pH-sensitive targeting anchor for honokiol (HK) nanoparticles.
• To enhance the targeting ability and therapeutic efficacy of HK nanoparticles using folic acid (FA) conjugation.

Main Methods:

• Preparation of honokiol (HK) nanoparticles coated with polydopamine (PDA) and conjugated with folic acid (FA) (HK-PDA-FA-NPs).
• Characterization of nanoparticle properties including particle size, potential, and morphology via transmission electron microscopy (TEM).
• In vitro assessment of nanoparticle stability in physiological media and pH-sensitive drug release.
• Evaluation of targeting ability towards 4T1 cells and in vivo tumor inhibition efficacy compared to unmodified HK-NPs.

Main Results:

• Successfully synthesized and characterized HK-PDA-FA-NPs with stable properties in various physiological media.
• Demonstrated pH-sensitive drug release behavior in vitro.
• Exhibited enhanced targeting ability of HK-PDA-FA-NPs to 4T1 cells compared to HK-NPs.
• Achieved a tumor inhibition rate greater than 80% in vivo, significantly outperforming ordinary HK-NPs.

Conclusions:

• Surface modification of HK-NPs with PDA and FA offers a promising and simplified approach for targeted cancer therapy.
• The developed HK-PDA-FA-NPs demonstrate superior targeting and therapeutic efficacy.
• This strategy represents a viable method for enhancing nanomedicine delivery to tumor sites.